Marc S. Raspanti is a partner in the nationwide Federal and State Whistleblower (Qui Tam) practice group of Pietragallo Gordon Alfano Bosick & Raspanti, LLP. The Founder of the firm’s national Qui Tam/False Claims Act practice group, Mr. Raspanti is based in the firm’s Philadelphia Office and also concentrates his practice in the areas of white collar criminal defense, health care fraud defense and complex commercial litigation.
Mr. Raspanti is widely recognized as one of the most successful, skilled and experienced qui tam attorneys in the United States. Since 1989, Mr. Raspanti has litigated many of the most complex and important cases in the history of the federal False Claims Act. Mr. Raspanti has served as lead counsel for whistleblowers in false claims cases that have resulted in nearly $2 billion in recoveries for federal and state taxpayers. Such cases include:
- United States ex rel. Lutz v. Berkeley Heartlab, Inc. et al., 14-230 (D.S.C.) (resulting in a $100 Million jury verdict for federal and state taxpayers)
- United States ex rel. Lutz v. Health Diagnostic Laboratory Inc., et al., 14-230 (D.S.C.) (resulting in a $47 Million recovery for federal and state taxpayers)
- United States ex rel. Merena v. Smithkline Beecham Clinical Laboratories, 93-5974 (E.D.Pa.) (resulting in a $334 Million recovery for federal taxpayers)
- United States ex rel. Monahan v. St. Barnabas Health System, 02-5702 (D.N.J.) (resulting in a $265 Million recovery for federal taxpayers)
- United States ex rel. DePace v. Cooper Health System, 08-5626 (D.N.J.) (resulting in a $12.6 Million recovery for federal taxpayers)
- United States ex rel. Hunt and Gauger v. Medco Health Solutions, 00-737 (E.D.Pa.) (resulting in a $185 Million recovery for federal and state taxpayers)
- United States ex rel. Michael Epp v. Supreme Foodservice AG, 10-1134 (E.D.Pa.) (resulting in a $389 Million civil and criminal recovery for federal taxpayers)
- United States et al ex rel. Bergman v. Abbott Laboratories, 09-4646 (E.D.Pa.) (resulting in a $25 Million recovery for federal and state taxpayers)
- United States ex rel. Bauchwitz v. Thomas Jefferson University et al., 04-2892 (successful representation of Thomas Jefferson University in defense of FCA action)
Mr. Raspanti is recognized across the United States as an authority on federal and state false claims act litigation and is frequently invited to speak to audiences across the United States. Mr. Raspanti has also written a number of authoritative articles on federal and state false claims statutes, including:
- “International Whistleblowing Legislation and America’s False Claims Act,” CEP Magazine, January 2020, at 16
- “Vive La Différence? American and French Healthcare Fraud, Waste, and Abuse Laws,” Compliance Today, December 2019
- “The Impact of International Whistleblowing on Global Corporate Compliance,” CEP Magazine, December 2019
- “Tips for Representing Corporations, Employees in Government Investigations,” Law360, October 2019
- “Exit Interviews – Do the Benefits Outweigh the Risks?,” The Legal Intelligencer, April 2019
- “Hiding in Plain Sight: Obtaining Insurance Coverage in White Collar Criminal Investigations and Complex Civil Litigation,” NACDL The Champion, April 2019
- “False Claims Act Cases Against Hospital Corporations,” Corporate Crime Reporter, November 2018
- “A Practitioner’s Primer on the History and Use of the Federal Anti-Kickback Statute,” AHLA Connections, March 2017
- “Are you FCPA Compliant?” Firm Newsletter, Winter 2016
- “What the Yates Memo Means for Federal Criminal and Civil Corporate Investigations?” Firm Newsletter, Winter 2016
- “A New Era of Laboratory Fraud: Part 2” HCCA Compliance Today, October 2016
- “A New Era of Laboratory Fraud: Part 1” HCCA Compliance Today, September 2016
- “The SEC’s New Admissions Policy Means Sometimes Having to Say You’re Sorry” NACDL The Champion, September/October 2015
- “Who Is Enforcing the Stark Law of the United States?” AHLA Connections, September 2012
- “The Tar Heel State Steps Up Its Fight Against Fraud” The Legal Intelligencer, June 26, 2012
- “What’s Next for the Year-Old SEC Whistleblower Program?” The Legal Intelligencer, November 1, 2011
- “Why is Qui Tam Litigation Often So Difficult to Resolve?” AHLA Connections, September 2011
- “The IRS’s Proposed Amendments to Its Informant Award Program,” The Legal Intelligencer, March 2, 2011
- “Proposed SEC Rules Undermine Dodd-Frank’s Whistleblower Incentives,” The Legal Intelligencer, February 10, 2011
- “The Minnesota False Claims Act: Is It Minnesota Nice?” Bench & Bar of Minnesota, April 2010
- “States, Statutes and Fraud: A Study of Emerging State Efforts to Combat White Collar Crime,” Cardozo Law Review, Issue 5, Volume 31, April 2010
- “The Employment Protection and Anti-Discrimination Provisions of the New Jersey State False Claims Act,” New Jersey Law Journal, August 10, 2009
- “The ‘New’ New Jersey False Claims Act: It was Born to Run,” The Legal Intelligencer (4 part series), July 6-9, 2009
- “Why Do They Do It?: The Motives, Mores, and Character of White Collar Criminals,” 82 St. John’s L. Rev. 401 (2008)
- “Modern False Claims Act Liability: Cradle to Grave Liability?” Health Lawyers News, Vol. 11, No 1 (Jan. 2007), Vol. 10, No. 12 (Dec. 2006)
- “False Claims Act Damages: One Size Doesn’t Fit All,” Health Lawyers News, Vol. 10, No. 7 (July 2006)
- “States, Statutes and Fraud: Empirical Study of Emerging State False Claims Acts,” 80 Tulane Law Review 465 (2005)
- “When Does Economic Credentialing Violate the Anti-Kickback Statute,” Health Law Handbook 307 (Alice Gosfield, ed., 2002 ed.)
- “Deterring Employees from Becoming Whistleblowers and Defending Against Whistleblower Suits brought by Employees,” Health Law Handbook 237 (Alice G. Gosfield, ed., 2001 ed.)
- “A Case Study: Department of Justice v. Qui Tam Relators,” Health Care Fraud (June 3, 1998)
- “Current Practice and Procedure under the Whistleblower Provisions of the Federal False Claims Act,” 71 Temple Law Review 23 (1998)
- “The Qui Tam Provisions of the False Claims Act: Even Success Has Its Challenges,” ABA Health Law Litigation, Summer (1996)
Mr. Raspanti is a creative and tenacious trial lawyer, who fights hard for his whistleblower clients. He has litigated virtually every phase of federal and state false claims cases, and has successfully teamed with federal and state false claims prosecutors across the United States. Mr. Raspanti has litigated against some of the largest companies in the United States on behalf of his clients.
A former prosecutor, who has been combating fraudulent and criminal conduct since 1984, Mr. Raspanti was previously appointed by Pennsylvania Governor Edward G. Rendell to serve as a Commissioner on the Pennsylvania Commission on Crime and Delinquency. From June 2007 through January 2010, Mr. Raspanti was also appointed as a Commissioner by Governor Rendell as the criminal defense representative to serve on the Pennsylvania Commission on Sentencing. The Commission creates a state-wide sentencing policy which promotes fair, consistent sentencing practices in order to provide judges with a common reference point for sentencing those convicted of felonies and misdemeanors.
In March 1999, Philadelphia Magazine named Mr. Raspanti one of the best white collar criminal defense lawyers in Philadelphia. Following that honor, Mr. Raspanti was selected by his peers as one of Pennsylvania’s Super Lawyers from 2004 through 2019 in the field of White Collar Criminal Defense, an honor reserved for 5% of the Pennsylvania Bar. In addition, in 2007 through 2015 he was listed as one of the Top 100 Pennsylvania Super Lawyers. In 2008 through 2015, he was selected as one of the Top 100 Philadelphia Super Lawyers. He was also selected by his peers for the 2006 through 2020 editions of Best Lawyers in America in the area of Health Care Law litigation. He was also included in the 2015 edition of Best Attorneys in Pennsylvania. Mr. Raspanti is Chambers & Partners rated in the area of Healthcare Litigation and White Collar Crime and Government Investigations. He was named the “Lawyer of the Year” for the Philadelphia Health Care sector for 2018.
In 2012, Mr. Raspanti was elected as a Fellow of the American College of Trial Lawyers, an organization devoted to recognizing outstanding civil and criminal trial lawyers in the United States and Canada. LexisNexis® Martindale-Hubbell® also recognizes Mr. Raspanti as an AV® Preeminent™ rated attorney, the highest such rating available to any individual lawyer in both legal ability and ethical standards.
Mr. Raspanti is a member of the Pennsylvania Association of Criminal Defense Lawyers (PACDL), the Society of Corporate Compliance and Ethics (SCCE), and an active member of the National Association of Criminal Defense Lawyers (NACDL). He also serves on the Federal Bar Association’s Committee on Complex Crimes Litigation and the Federal Criminal Law Committee for the Eastern District of Pennsylvania. Within the American Bar Association, Mr. Raspanti currently serves on the Sub-Committee on White Collar Crime and as the National Co-Chair of the Criminal Justice Section White Collar Sub-Committee on Qui Tam Litigation. Mr. Raspanti has been recognized as a national leader in his field by such organizations as Law Dragon 500 magazine and the US Healthcare Expert Guide. Mr. Raspanti is also an active member of the Health Care Compliance Association as well as the American Health Lawyers Association, where he frequently lectures and writes on current topics of interest.
Mr. Raspanti is a graduate of the Temple University School of Law and Villanova University.
Mr. Raspanti is admitted to practice in all courts in Pennsylvania, the District of Columbia (inactive), New York and numerous federal courts.